Protein Summary
May play a role in tumor angiogenesis.
- ENST00000311330
- ENSP00000308117
- ENSG00000174807
- CD164L1
- TEM1
- TEM1
- CD164L1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
protein domain | 0.97 | ||
gene perturbation | 0.84 | ||
cellular component | 0.66 | ||
tissue | 0.61 | ||
tissue sample | 0.56 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1833.47 (req: < 5)
Gene RIFs: 38 (req: <= 3)
Antibodies: 332 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1833.47 (req: >= 5)
Gene RIFs: 38 (req: > 3)
Antibodies: 332 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 9
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0